Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer

OBJECTIVE: To investigate the clinical value of lentinan combined with (125)I brachytherapy in the treatment of recurrent ovarian cancer. METHODS: A total of 160 patients with recurrent ovarian cancer admitted at Jiaozhou Central Hospital from June 2009 to October 2015 were enrolled in this study an...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Qin, Pang, Shuai, Xia, Yifang, Sun, Hongmei, Yu, Yingying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594994/
https://www.ncbi.nlm.nih.gov/pubmed/34795781
http://dx.doi.org/10.1155/2021/2472444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594994/
https://www.ncbi.nlm.nih.gov/pubmed/34795781
http://dx.doi.org/10.1155/2021/2472444

Ejemplares similares